Literature DB >> 16829143

Temporal relationship between MMP production and angiogenic process in HUVECs.

M S Kiran1, V B Sameer Kumar, R I Viji, P R Sudhakaran.   

Abstract

Alterations in both cell-cell and cell-matrix interactions are associated with the activation of endothelial cells that initiate angiogenesis. Cell-matrix interactions are affected by changes in both cell surface receptors for matrix proteins and the composition of ECM. One of the molecular mechanisms involved in changes in these components is the action of neutral proteinases, particularly matrix metalloproteinases. To understand the involvement of MMPs in angiogenic processes, the in vitro model of human umbilical vein endothelial cells in culture was used. Zymography and ELISA showed that, as cell-cell contact and network-like structures were formed, there was down regulation of MMP-2 and MMP-9 associated with high levels of their endogenous inhibitors TIMP-1 and TIMP-2. On treatment with aspirin, which inhibited the cell-cell contact and network-like structure formation, there was no down regulation of MMPs and cells continued to produce MMP-2 and MMP-9. These results indicate a temporal relationship between MMP-2 and MMP-9 production by endothelial cells and the onset of angiogenic event.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16829143     DOI: 10.1016/j.cellbi.2006.05.001

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  14 in total

1.  Modulation of endothelial nitric oxide synthase by fibronectin.

Authors:  R I Viji; V B Sameer Kumar; M S Kiran; P R Sudhakaran
Journal:  Mol Cell Biochem       Date:  2008-12-04       Impact factor: 3.396

2.  A novel composite construct increases the vascularization potential of PEG hydrogels through the incorporation of large fibrin ribbons.

Authors:  Mariah N Mason; Melissa J Mahoney
Journal:  J Biomed Mater Res A       Date:  2010-10       Impact factor: 4.396

Review 3.  Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.

Authors:  Kristine Y DeLeon-Pennell; Cesar A Meschiari; Mira Jung; Merry L Lindsey
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-18       Impact factor: 3.622

Review 4.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

5.  Procyanidins inhibit tumor angiogenesis by crosslinking extracellular matrix.

Authors:  Wan-Yin Zhai; Chun-Ping Jia; Hui Zhao; Yuan-Sen Xu
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

Review 6.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

7.  Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.

Authors:  Alexandros Theodoros Panagopoulos; Carmen Lucia Penteado Lancellotti; José Carlos Esteves Veiga; Paulo Henrique Pires de Aguiar; Alison Colquhoun
Journal:  J Neurooncol       Date:  2008-04-17       Impact factor: 4.130

8.  Changes in expression of VE-cadherin and MMPs in endothelial cells: Implications for angiogenesis.

Authors:  Manikantan S Kiran; Raveendran I Viji; Sameer Vb Kumar; Athira A Prabhakaran; Perumana R Sudhakaran
Journal:  Vasc Cell       Date:  2011-02-14

9.  Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma.

Authors:  Quan Huang; Song-Li Zhao; Xiao-Ying Tian; Bin Li; Zhi Li
Journal:  Int J Med Sci       Date:  2013-01-24       Impact factor: 3.738

10.  Inhibition of Angiogenesis In Vitro by Chebulagic Acid: A COX-LOX Dual Inhibitor.

Authors:  A P Athira; A Helen; K Saja; P Reddanna; P R Sudhakaran
Journal:  Int J Vasc Med       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.